- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aytu BioScience Inc (AYTU)
The Aytu BioScience share price today is 2.615, view NASDAQ AYTU stock exchange data. Track the latest Aytu BioScience share price with real-time updates on AYTU stock performance including market cap, day range, 52-week range and dividend yield. Access AYTU charts, earnings dates and analyst estimates to support your investment decisions.
2.615
+0.035(+1.36%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.550
2.615
52 wk Range
1.200
3.065
AYTU is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.5502.615
52 wk Range
1.2003.065
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AYTU Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
9.333
Upside
+256.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Form 8K Aytu BioScience Inc For: 2 April
- Investing.com
- Form 8K Aytu BioScience Inc For: 2 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.333
(+256.92% Upside)
Aytu BioScience Inc Earnings Call Summary for Q2/2026
- Aytu BioPharma reported Q2 2026 net revenue of $15.2 million, down from $16.2 million YoY, with gross margin declining to 63.5% and a net loss of $10.6 million ($5.00 per share).
- Stock fell 3.32% in aftermarket trading following the earnings release, with the ADHD portfolio generating $13.2 million in revenue despite overall company performance decline.
- The company has launched EXXUA, a new treatment for Major Depressive Disorder, with prescriptions already being filled across 27 states.
- Management projects reaching cash breakeven at $16.6 million in quarterly revenue and expects operating expenses between $4-5 million in the upcoming March quarter.
- Aytu maintains $30 million in cash and cash equivalents, with adjusted EBITDA at -$0.8 million as it navigates competitive pressures in ADHD and MDD treatment markets.
Last Updated: 04-02-2026, 03:48 am
Read Full TranscriptEarnings
Latest Release
03-02-2026
EPS / Forecast
-1.05 / --
Revenue / Forecast
15.17M / 15.55M
Compare AYTU to Peers and Sector
Metrics to compare | AYTU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAYTUPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | 2.7x | −0.5x | |
PEG Ratio | 0.02 | −0.70 | 0.00 | |
Price/Book | 2.0x | 1.6x | 2.6x | |
Price / LTM Sales | 0.4x | 2.2x | 3.2x | |
Upside (Analyst Target) | 168.2% | 73.9% | 48.8% | |
Fair Value Upside | Unlock | 4.0% | 6.9% | Unlock |
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Aytu BioScience (AYTU) Share Price Today?
The Aytu BioScience share price today is 2.615.
What is the current Aytu BioScience (AYTU) share price and day range?
As of 01-05-2026, the Aytu BioScience share price is 2.615, with a previous close of 2.580. The share price has ranged from 2.550 to 2.615 today, while the 52-week range spans from 1.200 to 3.065.
What Is the Aytu BioScience Market Cap?
As of today, Aytu BioScience market cap is 28.070M.
What Is the Aytu BioScience (AYTU) Share Price Target?
The average 12-month share price target for Aytu BioScience is 9.333, with a high estimate of 14 and a low estimate of 7. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +256.92% Upside potential.
What Is Aytu BioScience's Earnings Per Share (TTM)?
The Aytu BioScience EPS (TTM) is -3.032.
From a Technical Analysis Perspective, Is AYTU a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Aytu BioScience Trade On?
Aytu BioScience is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Aytu BioScience?
The stock symbol for Aytu BioScience is "AYTU."
How Many Times Has Aytu BioScience Stock Split?
Aytu BioScience has split 6 times.
How Many Employees Does Aytu BioScience Have?
Aytu BioScience has 83 employees.
What Is the AYTU Premarket Price?
AYTU's last pre-market stock price is 2.620. The pre-market share volume is 10.000, and the stock has changed by 0.040, or 1.550%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.